103 related articles for article (PubMed ID: 27939607)
1. Proteomic profiles of thyroid tumors by mass spectrometry-imaging on tissue microarrays.
Galli M; Pagni F; De Sio G; Smith A; Chinello C; Stella M; L'Imperio V; Manzoni M; Garancini M; Massimini D; Mosele N; Mauri G; Zoppis I; Magni F
Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):817-827. PubMed ID: 27939607
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiles of thyroid cancer subtypes: Classification based on features of tissue revealed by mass spectrometry imaging.
Pietrowska M; Diehl HC; Mrukwa G; Kalinowska-Herok M; Gawin M; Chekan M; Elm J; Drazek G; Krawczyk A; Lange D; Meyer HE; Polanska J; Henkel C; Widlak P
Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):837-845. PubMed ID: 27760391
[TBL] [Abstract][Full Text] [Related]
3. NanoLC-MS coupling of liquid microjunction microextraction for on-tissue proteomic analysis.
Quanico J; Franck J; Cardon T; Leblanc E; Wisztorski M; Salzet M; Fournier I
Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):891-900. PubMed ID: 27836619
[TBL] [Abstract][Full Text] [Related]
4. Proteomics for the diagnosis of thyroid lesions: preliminary report.
Pagni F; Mainini V; Garancini M; Bono F; Vanzati A; Giardini V; Scardilli M; Goffredo P; Smith AJ; Galli M; De Sio G; Magni F
Cytopathology; 2015 Oct; 26(5):318-24. PubMed ID: 25040579
[TBL] [Abstract][Full Text] [Related]
5. Classification of Thyroid Tumors Based on Mass Spectrometry Imaging of Tissue Microarrays; a Single-Pixel Approach.
Kurczyk A; Gawin M; Chekan M; Wilk A; Łakomiec K; Mrukwa G; Frątczak K; Polanska J; Fujarewicz K; Pietrowska M; Widlak P
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878024
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification.
Le Rhun E; Duhamel M; Wisztorski M; Gimeno JP; Zairi F; Escande F; Reyns N; Kobeissy F; Maurage CA; Salzet M; Fournier I
Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):875-890. PubMed ID: 27890679
[TBL] [Abstract][Full Text] [Related]
8. Imaging mass spectrometry in papillary thyroid carcinoma for the identification and validation of biomarker proteins.
Min KW; Bang JY; Kim KP; Kim WS; Lee SH; Shanta SR; Lee JH; Hong JH; Lim SD; Yoo YB; Na CH
J Korean Med Sci; 2014 Jul; 29(7):934-40. PubMed ID: 25045225
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of new biomarkers and application in thyroid cytology.
Torres-Cabala C; Bibbo M; Panizo-Santos A; Barazi H; Krutzsch H; Roberts DD; Merino MJ
Acta Cytol; 2006; 50(5):518-28. PubMed ID: 17017437
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.
Brown LM; Helmke SM; Hunsucker SW; Netea-Maier RT; Chiang SA; Heinz DE; Shroyer KR; Duncan MW; Haugen BR
Mol Carcinog; 2006 Aug; 45(8):613-26. PubMed ID: 16788983
[TBL] [Abstract][Full Text] [Related]
11. APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions.
Castelblanco E; Zafon C; Maravall J; Gallel P; Martinez M; Capel I; Bella MR; Halperin I; Temprana J; Iglesias C; Puig-Domingo M; Robledo M; Matias-Guiu X; Mauricio D
Thyroid; 2017 Jan; 27(1):59-66. PubMed ID: 27796194
[TBL] [Abstract][Full Text] [Related]
12. Typing of colon and lung adenocarcinoma by high throughput imaging mass spectrometry.
Kriegsmann M; Longuespée R; Wandernoth P; Mohanu C; Lisenko K; Weichert W; Warth A; Dienemann H; De Pauw E; Katzenberger T; Aust D; Baretton G; Kriegsmann J; Casadonte R
Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):858-864. PubMed ID: 27939606
[TBL] [Abstract][Full Text] [Related]
13. Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions.
Piga I; Casano S; Smith A; Tettamanti S; Leni D; Capitoli G; Pincelli AI; Scardilli M; Galimberti S; Magni F; Pagni F
Expert Rev Proteomics; 2018 Nov; 15(11):937-948. PubMed ID: 30290700
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of S100C in thyroid lesions.
Torres-Cabala C; Panizo-Santos A; Krutzsch HC; Barazi H; Namba M; Sakaguchi M; Roberts DD; Merino MJ
Int J Surg Pathol; 2004 Apr; 12(2):107-15. PubMed ID: 15173915
[TBL] [Abstract][Full Text] [Related]
15. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
16. Different desmin peptides are distinctly deposited in cytoplasmic aggregations and cytoplasm of desmin-related cardiomyopathy patients.
Shintani-Domoto Y; Hayasaka T; Maeda D; Masaki N; Ito TK; Sakuma K; Tanaka M; Kabashima K; Takei S; Setou M; Fukayama M
Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):828-836. PubMed ID: 28341603
[TBL] [Abstract][Full Text] [Related]
17. Discovery and Validation of Biomarkers That Distinguish Mucinous and Nonmucinous Pancreatic Cysts.
Park J; Yun HS; Lee KH; Lee KT; Lee JK; Lee SY
Cancer Res; 2015 Aug; 75(16):3227-35. PubMed ID: 26122842
[TBL] [Abstract][Full Text] [Related]
18. MALDI-MSI Analysis of Cytological Smears: The Study of Thyroid Cancer.
Mosele N; Smith A; Galli M; Pagni F; Magni F
Methods Mol Biol; 2017; 1618():37-47. PubMed ID: 28523498
[TBL] [Abstract][Full Text] [Related]
19. Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy.
Martínez-Aguilar J; Clifton-Bligh R; Molloy MP
Sci Rep; 2016 Mar; 6():23660. PubMed ID: 27025787
[TBL] [Abstract][Full Text] [Related]
20. Proteomics profiling of keratocystic odontogenic tumours reveals AIDA as novel biomarker candidate.
Ivanišević Malčić A; Breen L; Josić D; Jukić Krmek S; Džombeta T; Matijević J; Grgurević L; Pavelić K; Krušlin B; Kraljević Pavelić S
J Oral Pathol Med; 2015 May; 44(5):367-77. PubMed ID: 25040847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
